<DOC>
	<DOCNO>NCT01221025</DOCNO>
	<brief_summary>This prospective , double blind , placebo-controlled , parallel group study conduct three study center Guangzhou , China . Patients age old 65 ( ASA I-III ) undergo primary elective abdominal surgery general anesthesia involve study . According previous study pilot trial , sample size estimate 900 subject ( center recruit 300 patient ) . All eligible patient randomly assign one two group : study group receive parecoxib control group receive normal saline . All patient manage standard clinical anesthesia protocol sevoflurane-based general anesthesia continuous intravenous remifentanil , follow postoperative PCA morphine . The emergence delirium evaluate two person blind medication group use Riker sedation-agitation scale immediately since tracheal extubation specific time point patient discharge PACU . Pain intensity assessment pain relief assessment also conduct patient give time point 2 day postoperatively . The morphine-sparing effect , tolerability safety parecoxib investigate well .</brief_summary>
	<brief_title>Effect Study Parecoxib Treat Emergence Delirium Postoperative Pain</brief_title>
	<detailed_description>The inclusion criterion study include : - Aged old 65 ; - Primary elective abdominal surgery general anesthesia ; - Ability understand use pain assessment scale PCA device . The outcome measure study include : - Emergence Delirium Assessment ; - Pain intensity pain relief efficacy endpoint ; - Tolerability Safety Assessments</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Parecoxib</mesh_term>
	<criteria>Aged old 65 ; Body weight least 50 kg ; Primary elective abdominal surgery general anesthesia ; Preoperative health grade class ASA IIII , base medical history physical examination ; Ability understand use pain assessment scale PCA device Emergency revise abdominal surgery ; History know use analgesic agent could interfere analgesic response 24 h receipt study medication include NSAIDs , tricyclic antidepressant , neuroleptic antipsychotic agent , corticosteroid ( except routine preoperative medication ) ; History know suspected drug abuse ; Known allergy , sensitivity , contraindication opioid nonopioid analgesic drug ; History bleeding disorder , peptic ulceration , anticoagulant use within past month ; History asthma bronchospasm ; History inflammatory bowel disease , chronic acute renal hepatic disorder , coronary heart disease ; History dementia psychological disorder ; Contraindication parecoxib .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Parecoxib ;</keyword>
	<keyword>emergence delirium ;</keyword>
	<keyword>postoperative pain ;</keyword>
	<keyword>elderly patient ;</keyword>
	<keyword>abdominal surgery</keyword>
	<keyword>Parecoxib emergence agitation postoperative pain</keyword>
</DOC>